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Abstract
Background: The pathogenesis of autism spectrum disorder (ASD) remains a medical challenge even in the
developed world. Although genetics and epigenetic factors have been variously indicted as major causes of the
disorder, development of oxidative stress especially in the formative years of children has equally gained
prominence as an etiological basis of the disorder. Oxidative stress is characterized by the production of excessive
amounts of free radicals, decreased levels of antioxidants with the attendant imbalance in oxidant/antioxidant ratio.
This study was designed to determine the levels of essential metals [magnesium (Mg), zinc (Zn), and copper (Cu)]
and toxic metal, lead (Pb), and generation of oxidative stress by their abnormal interaction.
Method: Twenty-five children clinically diagnosed for ASD according to DSM-IV-TR and 25 neuro-typical (NT)
children (controls), (aged 5.96 ± 1.40 years and 6.18 ± 2.59 years respectively) were recruited for this study. Essential
and toxic metals were analyzed using induction-coupled plasma-mass spectrometry (ICP-MS); oxidative stress
markers [malondialdehyde (MDA), total plasma peroxidase (TPP), and total antioxidant capacity (TAC)] were
determined using appropriate biochemical methods. Oxidative stress index (OSI) was calculated.
Results: The levels of TPP and TAC were significantly reduced while MDA was higher in ASD compared to NT.
Although OSI was higher in ASD, the difference was not significant. Pb (lead) concentration was significantly
increased while Mg, Zn, and Cu levels were reduced significantly in ASD compared to NT. A significant negative
correlation between Mg and OSI (r = − 0.438; p = 0.029) was observed in NT.
Conclusion: Reduction in Zn and Mg levels with a concurrent increase in Pb in children with ASD in this study
may be the basis of inadequate TAC manifesting as increased MDA and reduced TPP levels. The attendant
imbalance in oxidant/antioxidant ratio may result in abnormality in neuronal transduction leading to the abnormal
cognitive and speech functions characteristic of ASD.
Keywords: Essential and toxic metals, Oxidative stress, Autism spectrum disorder, Imbalance in oxidant/antioxidant ratio

Introduction
Autism spectrum disorder (ASD) is a neurodevelopmental disorder that is becoming increasingly prevalent.
ASD is a heterogeneous group of neurodevelopmental
disorders characterized by impairments in verbal and
non-verbal expressive speech, deficits in social interaction
and hyper-focused repetitive behaviors [1, 2]. The causes
* Correspondence: ishiaqomotosh@yahoo.co.uk
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and pathophysiology of ASD are not fully understood.
There is a general agreement that ASD could result from
interaction between genetic and environmental factors
with oxidative stress as a potential link [3]. Oxidative
stress has recently been linked to the etiology of this
disorder along with multiple genetic and environmental
factors [4, 5]. Oxidative stress is characterized by the
production of excessive amounts of free radicals, decreased levels of antioxidants, or both. Excessive production of free radicals or impaired antioxidant mechanism
may cause oxidative stress which may induce several
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pathophysiological processes. Cellular antioxidant defense
mechanism prevents the generation of free radicals and
inactivates them after generation. Impaired antioxidant
defense mechanism can result in cell membrane damage,
alteration in membrane fluidity and permeability, and oxidative changes in proteins, lipids, and DNA [6]. Several
environmental factors like heavy metals particularly Pb
have been implicated in ASD. Understanding the levels of
anti-oxidative/oxidative status in children with ASD may
assist in clarifying the biochemical mechanisms underlying
the pathophysiology of these disorders. That the pathophysiology of ASD involve oxidative stress resulting from
exposure to heavy metals as environmental pro-oxidants
has been reported [6]; however, there are limited or no
information on this aspect of the disorder in sub-Sahara
Africa. This write-up, therefore, examines the impact of
exposure to some toxic and essential metals on levels of
oxidative stress markers/indices in the development of
ASD using black African children as a model.
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(Fiston centrifuge, manufactured in England) to obtain
plasma.
All samples were kept frozen at – 80 oC and were later
analyzed for metals and oxidative stress markers.
Essential and toxic metals were analyzed using ICPMS. Level of malondialdehyde (MDA) was estimated
using the method of Adam-Vizi and Seregi [7], Total
plasma peroxidase (TPP) was estimated using Fox-2 reagent as described by Uma Devi et al. [8] with minor
modifications by Harma et al. [9] and total antioxidant
capacity (TAC)] was determined using ferric reducing
antioxidant powder (FRAP) reagent as described by Benzie and Stram [10] while oxidative stress index (OSI)
was calculated as the ratio of total peroxide to the total
anti-oxidant capacity.
Statistical analysis was done using Statistical Package
for Social Science (SPSS 20. 0.1 for windows; SPSS Inc.,
Chicago, IL, 2016).
Descriptive statistics

Subjects and method

A total number of 50 participants were recruited into
this study. This comprised 25 children clinically diagnosed for ASD (5.25 ± 0.37 years) as cases by specialists
in child neurology and child psychiatry after proper evaluations and diagnosis using Diagnostic and Statistical
Manual of Mental Disorder (DMS-IV-TR) classification
and 25 neurotypical (NT) children (6.18 ± 2.2.59 years)
as controls. The control were recruited from friends, colleagues, and neighbors, unrelated to the case group. All
participants recruited for this study received routine
childhood vaccinations/immunization.
Ethical approval

Ethical approval was obtained from the UCH/UI joint
Ethical Committee (UI/EC/15/0087) and Oyo State
Ministry of Health Ethical Board. Informed consent was
obtained from each participant by proxy.
Inclusion criteria

Clinically diagnosed children with ASD that their parents gave informed consent were recruited for the study.
Exclusion criteria

Participants that were suffering from liver or kidney
disease, anemia, or current treatment for iron deficiency,
progressive neurological disorders, or epilepsy were
excluded from the study. None of the participants was
on psychotropic drug.
Blood sample was collected randomly from each participant from the ante-cubital vein. Blood was carefully
dispensed to avoid hemolysis into lithium heparin bottles. Blood samples were centrifuged at 2000 r.p.m. at
room temperature for 10 min using centeur 2-centrifuge

Mean standard error (± SEM) was used for parametric
numerical data, frequency, and percentage for nonnumerical data.
Analytical statistics

Student’s t test was used to assess the statistical significance of the difference between two study groups
means.
ANOVA test was used to assess the statistical significance of the difference between more than two study
groups means.
Chi-square test was used to examine the relationship
between two qualitative variables. Fisher’s exact test was
used to examine the relationship between two qualitative
variables when the expected count is less than 5 in more
than 20% of cells.
P value of 0.05 was considered significant.

Results
Table 1 is a summary of the biodata variables between
the autism spectrum disorders and neuro-typical children

The results showed no significant differences in all the
biodata variables except the birth weight that showed
significantly increased birth weight for ASD compared
to NT (p = 0). Although, there was a difference in birth
weight of cases and controls, the two groups were comparable based on other biodata obtained through structured questionnaire.
Also, the summary of mean ± SEM of essential trace
metals and toxic metal between ASD and NT showed
significant differences in all the biochemical parameters.
Mg, Zn and Cu were significantly reduced in ASD compared to NT (p < 0.000; p < 0.000 and p < 0.049) respectively. Zn/Cu ratio was also significantly reduced in
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Table 1 Comparison of Biodata and Biochemical Variables Between ASD and NT Groups Using Student T- Test
VARIABLES

ASD
(N = 25)

NT
(N = 25)

t-VALUE

P-VALUE

Child’s Age (yrs)

5.96 ± 1.45

6.18 ± 2.2.59

− 0.370

0.713

Mother’s Age at Birth (yrs)

26.68 ± 2.69

27.96 ± 2.70

−1.680

0.100

Father’s Age at Birth (yrs)

31.72 ± 2.98

32.32 ± 3.86

−0.615

0.541

Number of Siblings

1.72 ± 0.79

1.60 ± 0.91

0.497

0.622

Child’s weight (kg)

19.64 ± 3.99

19.00 ± 5.18

0.490

0.627

Mg (mg/dl)

2.53 ± 0.46

3.13 ± 0.43

−4.830

0.000*

Zn (μg/dl)

222.3 ± 63.8

438.5 ± 185.5

−5.511

0.000*

Cu (μg/dl)

4.32 ± 1.02

4.88 ± 0.94

−2.020

0.049*

Zn/Cu

55.31 ± 22.04

92.29 ± 44.57

−3.719

0.001*

Pb (μg/dl)

9.49 ± 4.04

5.43 ± 2.04

4.483

0.000*

Total Plasma Peroxidase (TPP)

105.9 ± 2.3

110.4 ± 7.9

−2.679

0.010*

Total Antioxidant Capacity (TAC)

280.2 ± 34.4

303.8 ± 33.1

−2.468

0.017*

Malondialdyde (×10−5) (MDA)

2.27 ± 0.23

1.42 ± 0.13

16.127

0.000*

Oxidative Stress Index (OSI)

0.38 ± 0.05

0.37 ± 0.05

1.083

0.284

*Significant at p < 0.05

ASD compared to NT (p < 0.001). Pb on the other hand
was significantly higher in ASD than in NT (p < 0.000).
Aside this,
mean ± SEM levels of oxidative stress
markers in ASD and NT showed that TPP and TAC
were reduced (p < 0.010; p < 0.017) while MDA was
higher in ASD compared to NT (p < 0.000). Although
OSI was higher in ASD, the difference between the two
groups was not significant (p > 0).

Table 3 is a summary of correlation analysis between
trace metals (including Pb) and oxidative stress markers
in ASD children

There was a significant negative correlation between Mg
and OSI (r = -0.438; p = 0.029) and a significant positive
correlation between Zn and Zn/Cu ratio (r = 0.907; p =
0.000).
Table 4: Correlation of Zn/Cu ratio with Oxidative indices
in Children with ASD

Table 2: Correlation of levels of essential and toxic metals
level with oxidative markers in NT

There were no significant correlations among the trace
metals (including Pb) and oxidative markers in Neurotypical children. However, expressing concentration of Cu
as a ratio of Zn showed that Mg positively correlated
with Zn/Cu ratio (r = 0.589; p = 0.002). Cu had negative
correlation with Zn/Cu ratio (r = -0.785; p = 0.000)
while Zn positively correlated with the ratio (0.839; p =
0.000).

No significant correlations were observed among
markers of oxidative stress including with Zn/Cu ratio
in children with ASD except between OSI and TAC (r =
-0.983, p = 0.000) where a highly significant negative
correlation was obtained.
Table 5: Correlation of Zn/Cu ratio with Oxidative indices
in NT Children

The results of correlation analysis of markers of oxidative stress and Zn/Cu ratio in neurotypical children were

Table 2 Correlation of levels of essential and toxic metals level with oxidative markers in NT
Mg

Zn

Cu

Pb

*Significant at P < 0.05

TPP

TAC

MDA

OSI

Zn/Cu

r

−0.182

0.058

0.006

−0.092

0.589

P

0.384

0.784

0.979

0.663

0.002*

r

−0.128

0.147

0.260

−0.172

0.839

p

0.542

0.483

0.209

0.411

0.000*

r

0.384

0.202

0.095

−0.151

− 0.785

p

0.058

0.334

0.653

0.472

0.000*

r

−0.109

−0.105

−0.036

0.039

0.048

p

0.602

0.619

0.866

0.853

0.821
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Table 3 Correlation of toxic and essential metals levels with oxidative stress markers in ASD
Mg

Zn

Cu

Pb

TPP

TAC

MDA

OSI

Zn/Cu

r

− 0.337

0.291

0.284

−0.438

0.378

p

0.099

0.158

0.169

0.029*

0.063

r

0.055

0.158

0.192

−0.106

0.907

p

0.793

0.452

0.357

0.613

0.000*

r

0.222

−0.077

− 0.133

0.170

− 0.302

p

0.287

0.715

0.527

0.417

0.142

r

−0.195

−0.165

0.303

−0.004

0.238

p

0.350

0.431

0.140

0.986

0.252

*Significant at p < 0.05

also not significant. Like in ASD children, a highly significant negative correlation was obtained between OSI
and TAC (r = -0.832, p = 0.000); however, contrary to
those of ASD, a highly positive significant correlation
was equally obtained between OSI and TPP in Neurotypical children (r = 0.696, p = 0.000).

Discussion
This study was designed to determine the interplay of
oxidative stress markers (TAC, TPP, MDA, and OSI)
and essential and toxic metals (Mg, Zn, Cu, and Pb) in
the pathophysiology of ASD. In this environment, this
study was the first to examine oxidative stress markers
in children with ASD in Nigeria.
The metabolic function of Mg and Ca has been
copiously reported [3, 11, 12]; they are also cofactors in
many enzymes in the body including those involved in
neurogenesis [13].

In heavy metal toxicity, both Mg and Ca may be
displaced by heavy metals like Pb thus changing the molecular configuration of the catalyzing enzyme with its
attendant negative consequences. Hence, a reduction in
level of these essential metals as seen in this study especially in the central nervous system may initiate a deficit
in the neurological functions of the metals. Their deficiency may also elicit replacement in some of the enzymatic processes where they are involved or may
exacerbate accumulation of other toxic metals leading to
deleterious effect of the latter especially oxidation in sensitive organs like the brain. The observed reduced Mg
level in children with ASD in this study may clearly
corroborate this. Mg deficiency has been reported to increase NO accumulation and lipid peroxidation and
lowers plasma antioxidants levels [6, 14]. Its deficiency
has also been reported to increase oxidative stress which
was reversed by its supplementation in laboratory

Table 4 Correlation of Zn/Cu ratio with oxidative indices in children with ASD
Correlations in ASD
TPP

TPP

TAC

MDA

OSI

Zn/Cu

1

−.083

.041

.225

−.180

.692

.846

.279

.389

N

25

25

25

25

25

Pearson Correlation

−.083

1

.360

-.983a

−.093

Sig. (2-tailed)

.692

.077

.000

.659

N

25

25

25

25

25

Pearson Correlation

.041

.360

1

−.369

−.039

Pearson Correlation
Sig. (2-tailed)

TAC

MDA

OSI

Zn/Cu

a

Sig. (2-tailed)

.846

.077

.069

.852

N

25

25

25

25

25

Pearson Correlation

.225

-.983a

−.369

1

.065

Sig. (2-tailed)

.279

.000

.069

N

25

25

25

25

25

Pearson Correlation

−.180

−.093

−.039

.065

1

.759

Sig. (2-tailed)

.389

.659

.852

.759

N

25

25

25

25

Correlation is significant at the 0.01 level (2-tailed)

25
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Table 5 Correlation of Zn/Cu ratio with Oxidative indices in NT children
Correlations IN NT
TPP

TPP

TAC

MDA

OSI

Zn/Cu

1

−.198

−.067

.696a

−.031

.344

.752

.000

.883

N

25

25

25

25

Pearson Correlation

−.198

1

−.136

−.832

.216

Sig. (2-tailed)

.344

.518

.000

.300

Pearson Correlation
Sig. (2-tailed)

TAC

MDA

OSI

Zn/Cu

25
a

N

25

25

25

25

25

Pearson Correlation

−.067

−.136

1

.040

.241

Sig. (2-tailed)

.752

.518

.849

.245

N

25

25

25

25

25

Pearson Correlation

.696a

−.832a

.040

1

−.190

Sig. (2-tailed)

.000

.000

.849

.364

N

25

25

25

25

25

Pearson Correlation

−.031

.216

.241

−.190

1

Sig. (2-tailed)

.883

.300

.245

.364

N

25

25

25

25

25

a

Correlation is significant at the 0.01 level (2-tailed)

animals [15]. Hence, findings in this study were similar
to earlier works reporting reduced Mg level in children
with ASD as a possible basis of observed lipid peroxidation and increased NO accumulation in this disorder.
Zn is also an essential trace metals involved in catalytic
activities of over 300 enzymes and plays a crucial role in
protein synthesis, immune system and cell division [16,
17]. Zn deficiency has been reported to predispose individuals to development of neuropsychological changes
like emotional imbalance, depression and irritability and
cognitive disorders [16]. It has also been reported that
reduced Zn level exacerbates Cu toxicity [18]. Because
of the very crucial roles of this essential metal in many
metabolic activities in the body, downregulation of its
level as observed in children with ASD in this study in
comparison to what obtained in NT children may be significant in the observed dysfunction and clinical symptoms associated with ASD. The expected role of Zn in
protein synthesis and cell division may be easily compromised in these children leading to abnormality in
DNA synthesis and its attendant effect on genetic
composition especially in the brain. One of the metabolic functions of Zn is its modulatory role on Cu absorption at the intestinal level. The redox potential of
Cu is also said to be closely linked with its rate of
absorption in the intestine [19]. Aside from its role in
redox reactions, Cu is also an important cofactor in
many metalloenzymes. These antioxidative functions
of Cu as a redox metal are largely dependent on the
Zn/Cu combination in metallothionein. This molecule
has been implicated as regulator molecules in gene

expression, homeostatic control of cellular metabolism
of metals, and detoxifying agent against toxic metals.
As observed in this study, there was a downregulation
of Zn with the attendant imbalance in the Zn/Cu ratio.
This might have precipitated a concurrent reduction in
the metallothionein level and a deficit in the function of
the latter. The consequence of this may be generation of
oxidative stress which the imbalance in Zn/Cu ratio may
have induced. The imbalance in the level of the two essential metals has been attributed to pathological
changes in the intestinal mucosa in ASD leading to a
downregulation of Zn and its consequent impairment of
antioxidant defenses and impairment of DNA repair especially in sensitive organs like the brain [16, 20–22]. It
has also been previously reported that Zinc induces the
intestinal synthesis of a copper-binding protein such as
metallothionein. Metallothionein traps copper within intestinal cells and prevents its systemic absorption [23].
Thus, a reduction in the expected Zn level as seen from
results of this work may have reduced the synthesis of
metallothionein and its implication on the modulatory
functions of this Zn/Cu molecule in attenuating toxicity
of heavy metals.
In this study, Zn/Cu ratio in NT children was 1:1; although some workers have postulated an inverse relationship in levels of the two metals in NT children [24];
hence, however, the observed reduction in Zn level in
children with ASD in this study resulting in a reduction
in the ratio may precipitate a reduction in the concentration of metallothionein required for the necessary antioxidative activities of the essential metals. Although
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results from previous study by Lakshmi and Geetha [25]
who found increased Cu levels in ASD, the contradiction
may be due to the presence of intestinal malnutrition
and malabsorption of Cu in children with ASD in this
study. As it has been previously reported, Zn has been
associated with Cu absorption in the intestine; unfortunately, presence of malnutrition and/or malabsorption
was not investigated in this study.
Hence, it has been proposed that the plasma Zn/serum
Cu ratio may be used as a rapid method of determining
the functional state of the metallothionein system [26]
and by inference the capability of the system to
neutralize the toxic effects of heavy metals.
Lead is an established toxicant affecting functions of
both central and peripheral nervous systems [27, 28]. Its
various domestic and industrial application in the environment and ability to cross biological barrier to accumulate in the internal organs has largely facilitated its
toxicity in the body affecting behavior and cognitive
functions. The observed elevated Pb level in this study
may have been facilitated by the reduction in Zn with
the consequent reduction in metallothionein which
physiologically could have prevented the accumulation
and toxicity of Pb. Results from this study were similar
to those of previous studies that reported increased Pb
level in children with ASD [29]. The issue of reduced
ability to detoxify and eliminate toxic metals like Pb as
reported by other workers [19, 30–32] which is largely a
function of the amount of metallothionein formed has
also been seen in this study.
It may therefore be stated that children with ASD in
this study have suffered the pathological consequences
of increased oxidative stress due to a reduction in Zn
level and the consequent reduction in metallothionein
formation leading to accumulation and toxicity of Pb.
Markers of oxidative stress determined in this study
were TAC, TPP, MDA, and OSI. The presence of essential metals like Zn, Cu, and Mg in collaboration with
other systemic antioxidants was expected to moderate a
balance in levels of oxidants and antioxidants to allow
for a conducive milieu for normal metabolic activities.
This is especially required in sensitive organs like the
brain. A reduction in Zn and Mg levels with a concurrent increase in Pb seen in cases in this study may be a
good and veritable basis for accumulation of oxidants
overwhelming the other antioxidant pathways with the
possible creation of an imbalance in the oxidant/antioxidant pool of the body. The reduced TAC level seen in
children with ASD in this study could be traced to increased MDA and reduced TPP levels which collectively
would overwhelm the antioxidant pool of the body. TPP
is an indication of the peroxidase capability in the membrane which with reference to the neuron will have a
deleterious effect on its transmission capability. This
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effect may be accentuated by an increase in MDA level
exacerbating the ROS and by implication the oxidation
processes at the neural level. The increased Pb level in
cases seen in this study may be a clear indication of the
source of the increased MDA and reduced TPP which
may explain the abnormal cognitive and speech functions characteristic of ASD. Previous studies have reported alteration in composition of fatty acids, oxidation
of lipids and phospholipids of the membrane of cells in
children with ASD [32, 33]; all these may have direct
effect on the functions of proteins that are involved in
signal transduction, an important process required in
neural transmission.
Elevation of MDA level is suggestive of damage to the
lipid component of the cell which may lead to alteration
in membrane lipid metabolism, such as composition of
fatty acid content of the cell. The ultimate effect of this
is its adverse effect on transduction and transmission
processes involving these proteins.
Hence, an imbalance in oxidant/antioxidant system of
the body especially in sensitive organs like the brain may
lead to structural damage due to the deleterious effects
of ROS and the attendant disruption in transduction and
transmission of signals across neurons. This finding is
similar to previous ones where reduced activity of antioxidant enzymes like glutathione peroxidase and superoxide dismutase as well as plasma glutathione
concentration was reported in ASD [34–37].

Conclusion
This study showed that decreased levels of Zn and Mg is
a possible etiological basis for accumulation of Pb leading to increase in oxidative stress with a reduction in
TAC and the attendant abnormal neurological sequelae
associated with children with ASD in this environment.
Limitations
Due to the level of understanding of research benefits in
the African setting, it has not been easy recruiting participants for this study; this has thus caused the limited
sample size of the study. Lack of funding for the project
ostensibly due to the same reason has also affected the
scope of works carried out in this project. Also, for cultural reasons, non-invasive methods like nail or hair analysis could not be used in this environment. The use of
blood analysis in this project has greatly affected the
sample size and by implication some of the statistical
tools that could be applied in the analysis of results. The
sociodemographic data obtained from participants in the
study might have indicated variations in the socioeconomic status of the babies while corrections could not
be made for multiple comparisons arising from the
above differences.
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